Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)
Antwerpes, S.; Protopopescu, C.; Morlat, P.; Marcellin, F.; Wittkop, L.; Di Beo, V.; Salmon-Céron, D.; Sogni, P.; Michel, L.; Carrieri, M.P.; the ANRS CO13 HEPAVIH Study Group. Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH). Nutrients 2020, 12, 2532. https://doi.org/10.3390/nu12092532
Antwerpes S, Protopopescu C, Morlat P, Marcellin F, Wittkop L, Di Beo V, Salmon-Céron D, Sogni P, Michel L, Carrieri MP, the ANRS CO13 HEPAVIH Study Group. Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH). Nutrients. 2020; 12(9):2532. https://doi.org/10.3390/nu12092532
Chicago/Turabian StyleAntwerpes, Saskia, Camelia Protopopescu, Philippe Morlat, Fabienne Marcellin, Linda Wittkop, Vincent Di Beo, Dominique Salmon-Céron, Philippe Sogni, Laurent Michel, Maria P. Carrieri, and the ANRS CO13 HEPAVIH Study Group. 2020. "Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)" Nutrients 12, no. 9: 2532. https://doi.org/10.3390/nu12092532